Insights
What should a portfolio company do about AI in the first 100 days?
The first 100 days set the trajectory, and AI is now part of the value-creation plan whether or not it was in the deal thesis. The pressure is real — a board expecting a view, management with a hundred competing priorities, and a hold period measured in years, not decades. The temptation is either to do nothing yet or to launch a sweeping transformation. Both waste the window. The first 100 days are for a diagnosis and a few honest wins, not a moonshot.
This is how to use them.
Why the first 100 days
Attention and mandate are never higher than at the start of a hold. It is the moment when a new plan is expected, budget is being set, and the organisation is braced for change anyway. Spend that window on a genuine read of where AI can create value — and a couple of visible early wins — and you set an agenda the rest of the hold can build on. Let it drift, and AI becomes a standing "we should look at that" item that never gets a serious hearing again until it is too late to matter for the exit.
Don't start with a transformation
The instinct to announce an ambitious AI programme is the thing to resist. Big-bang transformations in the first quarter, before anyone understands the business's data, processes, or people, are how budget gets spent on science projects that never reach production. Start instead with a diagnosis: where does AI actually move a number here, what is the business ready for, and where are the risks. Pair that with one or two low-risk wins that prove the value is real. Credibility earned early is what funds the ambitious work later.
The 100-day arc
A workable shape trades the moonshot for momentum.
| Phase | Focus | Output |
|---|---|---|
| Weeks 1–4 | Get literate and honest | Leadership up to speed on what AI can and can't do; a baseline of where AI is already used, and where value might sit |
| Weeks 5–8 | Benchmark and govern | A read of AI maturity against the peer group; the governance and EU AI Act gaps identified; a shortlist of high-value uses |
| Weeks 9–13 | Prove and plan | One or two quick wins delivered against a baseline; a costed, board-ready roadmap for what to fund next |
The arc deliberately front-loads understanding and back-loads commitment. You reach the funding decision with evidence — a benchmark, a governance view, and a proven win — rather than with a slide deck and a hope.
What to put in front of the board
The output an investment committee can act on is not a list of tools; it is a roadmap that reads like any other value-creation lever: the value at stake, the cost to capture it, the risk (including governance and regulatory exposure), and a specific ask. Presented that way, AI competes for capital on the same terms as everything else in the plan, which is exactly where it should sit. A board funds a costed decision far more readily than an enthusiasm.
Portfolio-wide leverage
The quiet advantage for a PE firm is that the first-100-days playbook is repeatable. The diagnosis, the governance baseline, the benchmark, and the roadmap follow the same shape at each portfolio company, even as the answers differ. Run it once well and you have a template — and a growing view across the portfolio of where AI is creating value and where it is stalling — that turns a company-by-company scramble into an operating discipline. That is where the compounding return sits, not in any single tool.
Taking a portfolio company from AI uncertainty to a costed, board-ready roadmap in six weeks — literacy, benchmark, governance, and a proven win — is exactly what Firestarter's accelerator is built for, and it runs the same way across a portfolio.